Skip to content
10-Q

Quarterly Report

Sanomedics, Inc.

0001477932-15-003451

← back to feed
Filed
May 20, 2015 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2015 · May 18, 2015 18M sh
Cash And Equivalents Q1 2015 · Mar 31, 2015 $42.12K
Cash And Equivalents Q1 2015 · Dec 31, 2014 $210.14K
Cash And Equivalents Q1 2015 · Mar 31, 2014 $181.02K
Cash And Equivalents Q1 2015 · Dec 31, 2013 $9.56K
Stockholders Equity Q1 2015 · Mar 31, 2015 −$4.78M
Stockholders Equity Q1 2015 · Dec 31, 2014 −$5.05M
Current Liabilities Q1 2015 · Mar 31, 2015 $5.02M
Current Liabilities Q1 2015 · Dec 31, 2014 $5.46M
Total Liabilities Q1 2015 · Mar 31, 2015 $5.21M
Total Liabilities Q1 2015 · Dec 31, 2014 $5.91M
Current Assets Q1 2015 · Mar 31, 2015 $402.06K
Current Assets Q1 2015 · Dec 31, 2014 $813.57K
Total Assets Q1 2015 · Mar 31, 2015 $430.43K
Total Assets Q1 2015 · Dec 31, 2014 $853.44K
Sga Expense Q1 2015 · Mar 31, 2015 $608.82K
Sga Expense Q1 2015 · Mar 31, 2014 $595.42K
Net Income Q1 2015 · Mar 31, 2015 −$697.64K
Net Income Q1 2015 · Mar 31, 2014 −$1.43M
Operating Income Q1 2015 · Mar 31, 2015 −$475.59K
Operating Income Q1 2015 · Mar 31, 2014 −$720.7K
Gross Profit Q1 2015 · Mar 31, 2015 $161.67K
Gross Profit Q1 2015 · Mar 31, 2014 $123.12K
Cost Of Revenue Q1 2015 · Mar 31, 2015 $28.14K
Cost Of Revenue Q1 2015 · Mar 31, 2014 $18.69K
Capex Q1 2015 · Mar 31, 2014 $10.37K
Rd Expense Q1 2015 · Mar 31, 2014 $22.51K